Related Experiment Videos
Nonvalvular atrial fibrillation and primary stroke prevention from a geriatric point of view
1Afdeling Geriatrie Dienst Inwendige Geneeskunde, Universitaire Ziekenhuizen, K.U. Leuven.
Insights
Elderly patients with atrial fibrillation face high stroke risk. Anticoagulant therapy effectively prevents strokes, but geriatricians show reluctance in prescribing it for nonvalvular atrial fibrillation.
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- Cerebrovascular disease is a leading cause of mortality.
- Atrial fibrillation significantly increases stroke risk.
- Nonvalvular atrial fibrillation poses a substantial cerebrovascular threat.
Purpose of the Study:
- To evaluate the risks and benefits of anticoagulant therapy for stroke prevention.
- To address the reluctance of geriatricians in prescribing anticoagulants.
- To provide evidence-based guidance for managing nonvalvular atrial fibrillation in the elderly.
Main Methods:
- Review of large randomized trials on anticoagulant efficacy.
- Analysis of data concerning stroke prevention in nonvalvular atrial fibrillation.
- Assessment of risks versus benefits in geriatric populations.
Main Results:
- Oral anticoagulant therapy is proven effective in primary stroke prevention for nonvalvular atrial fibrillation.
- Geriatricians exhibit hesitancy in prescribing anticoagulants despite demonstrated efficacy.
- Balancing bleeding risks with stroke prevention benefits is crucial.
Conclusions:
- Anticoagulant therapy is a vital tool for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
- Addressing geriatrician reluctance requires further education and evidence dissemination.
- Optimizing stroke prophylaxis in this demographic necessitates careful risk-benefit assessment.
Abstract:
Cerebrovascular disease constitutes one of the major causes of death. Patients with atrial fibrillation are known to be at high risk for stroke. The efficacy of oral anticoagulant therapy in the primary prevention of stroke in individuals with nonvalvular atrial fibrillation has been demonstrated in several large randomized trials. However, many geriatricians remain reluctant to prescribe anticoagulants. This article focuses on the risks and benefits of stroke prophylaxis with anticoagulant therapy in elderly patients with nonvalvular atrial fibrillation.